Unique ID issued by UMIN | UMIN000027997 |
---|---|
Receipt number | R000032061 |
Scientific Title | Efficacy of eicosapentaenoic acid on the prevention of preterm birth in women with cervical shortening |
Date of disclosure of the study information | 2017/08/01 |
Last modified on | 2020/07/01 17:59:21 |
Efficacy of eicosapentaenoic acid on the prevention of preterm birth in women with cervical shortening
Efficacy of eicosapentaenoic acid on the prevention of preterm birth in women with cervical shortening
Efficacy of eicosapentaenoic acid on the prevention of preterm birth in women with cervical shortening
Efficacy of eicosapentaenoic acid on the prevention of preterm birth in women with cervical shortening
Japan |
threatened preterm delivery
Obstetrics and Gynecology |
Others
NO
To determine whether eicosapentaenoic acid supplementation reduce the incidence of preterm birth in women with cervical shortening.
Efficacy
Preterm birth
1)gestational age at delivery
2)Birth weight, Apgar score, pH of umbilical arterial blood
3)Cervical length
4)Maternal adverse event
5)Neonatal adverse event
6)Occurrence of adverse events toward neonates
7)Duration of hospital stays
8)Duration of use of a tocolytic agent (ritodrine hydrochloride preparation, magnesium sulfate preparation)
9)Nutrient intakes
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine |
Participants take eicosapentaenoic acid 1800mg per day from the day of confirming cervical shortening to 35w6d of gestation or the day of delivery when the deliery occurs before 35w6d.
20 | years-old | <= |
Not applicable |
Female
1)Between 24 to 28weeks of gestation, pregnant women with shortened cervix length (< or = 25 mm)
or Between 29 to 33weeks of gestation, pregnant women with shortened cervix length (< or = 30 mm)
2)Pregnant woman who is at 20 years old or more.(at the time of informed consent)
3)Patients who were required to provide written informed consent
1)Patients who was transferred from other hospitals
2)Patients with a past history of conization
3)Patients who underwent cervical cerclage in current pregnancy
4)Premature rupture of the membrane
5)fetal anomalies detected by ultrasonography
6)Prolapsed fetal membranes
7)Chorioamnionitis
8)White blood cell count > or =15,000/mm3
or CRP > or =1.0mg/dl
9)Placenta previa
10)Multiple pregnancy
11)Painful degeneration of myomas during pregnancy
12)Uterine malformations
13)Previous medication of eicosapentaenoic acid
14)Medication with low-dose aspirin
15)Patients judged to be ineligible by attending physician
128
1st name | Takeshi |
Middle name | |
Last name | Nagamatsu |
The University of Tokyo Hospital
Obstetrics and Gynecology
113-8655
7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 JAPAN
03-3815-5411
tnag-tky@umin.ac.jp
1st name | Takeshi |
Middle name | |
Last name | Nagamatsu |
The University of Tokyo Hospital
Obstetrics and Gynecology
113-8655
7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 JAPAN
03-3815-5411
tnag-tky@umin.ac.jp
The University of Tokyo Hospital
MSD life science foundation, public interest incorporated foundation
Non profit foundation
Aiiku hospital
Office for Human Research Studies (OHRS), university of Tokyo
7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 JAPAN
03-5841-0818
ethics@m.u-tokyo.ac.jp
NO
2017 | Year | 08 | Month | 01 | Day |
Unpublished
99
No longer recruiting
2017 | Year | 06 | Month | 29 | Day |
2017 | Year | 07 | Month | 31 | Day |
2017 | Year | 08 | Month | 01 | Day |
2020 | Year | 09 | Month | 30 | Day |
2017 | Year | 06 | Month | 29 | Day |
2020 | Year | 07 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032061
Research Plan | |
---|---|
Registered date | File name |
2020/07/01 | b_研究計画書_2018009SP_.docx |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |